141 related articles for article (PubMed ID: 17589531)
21. Immune evasion strategies of pediatric precursor-B acute lymphoblastic leukemia after allogeneic bone marrow transplantation-a case study.
Barbaric D; Wynne K; Aslanian S; Bond M; Reid GS
Leuk Res; 2005 Jun; 29(6):711-4. PubMed ID: 15863213
[TBL] [Abstract][Full Text] [Related]
22. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
[TBL] [Abstract][Full Text] [Related]
23. Acute myeloid leukemia with concurrent myeloid sarcoma treated with autologous bone marrow transplantation: two illustrative cases and a literature review.
Finnegan DP; Jones FG; McMullin MF
Hematol Oncol; 2005; 23(3-4):133-5. PubMed ID: 16273593
[TBL] [Abstract][Full Text] [Related]
24. Secondary acute myeloid leukemia after autologous bone marrow transplantation for malignant lymphomas.
Marolleau JP; Brice P; Morel P; Gisselbrecht C
J Clin Oncol; 1993 Mar; 11(3):590-1. PubMed ID: 8445439
[No Abstract] [Full Text] [Related]
25. Cancer of the esophagus following allogeneic bone marrow transplantation for acute leukemia.
Atree SV; Crilley PA; Conroy JF; Micaily B; Brodsky JT
Am J Clin Oncol; 1995 Aug; 18(4):343-7. PubMed ID: 7625377
[TBL] [Abstract][Full Text] [Related]
26. Therapy of secondary leukemia.
Rowe JM
Leukemia; 2002 Apr; 16(4):748-50. PubMed ID: 11960361
[No Abstract] [Full Text] [Related]
27. Transmission of a follicular lymphoma by allogeneic bone marrow transplantation--evidence to support the existence of lymphoma progenitor cells.
Hart J; Turner AR; Larratt L; Russell J; Franko B; Frantz C; Paonessa T; Mansoor A; Lai R
Br J Haematol; 2007 Jan; 136(1):166-7. PubMed ID: 17096686
[No Abstract] [Full Text] [Related]
28. Persistent infection with human T lymphotropic virus type 1 after allogeneic bone marrow transplantation from a seronegative donor.
Kanda Y; Taketazu F; Chiba S; Yazaki Y; Hirai H
Bone Marrow Transplant; 1999 Aug; 24(3):349. PubMed ID: 10455380
[No Abstract] [Full Text] [Related]
29. Ethics. Did the NHS fail child B?
Nurs Times; 1996 Sep 4-10; 92(36):33-6. PubMed ID: 8868766
[No Abstract] [Full Text] [Related]
30. Acute lymphoblastic leukaemia relapsing with solid hepatic tumours after bone marrow transplantation.
Miyoshi I; Uemura Y; Taguchi H; Sugimoto T
Br J Haematol; 2004 Nov; 127(4):372. PubMed ID: 15521912
[No Abstract] [Full Text] [Related]
31. ABO incompatibility and relapse risk in patients undergoing allogeneic marrow transplantation for acute myeloid leukemia.
Mielcarek M; Torok-Storb B; Storb R
Bone Marrow Transplant; 2002 Oct; 30(8):547-8; author reply 548. PubMed ID: 12379898
[No Abstract] [Full Text] [Related]
32. Two secondary malignancies following the successful treatment of a patient with acute lymphoblastic leukemia.
Garcia-Boyero R; Sanz GF; Sanz MA
Ann Oncol; 1996 Mar; 7(3):322-3. PubMed ID: 8740801
[No Abstract] [Full Text] [Related]
33. B-cell lymphoma of recipient origin 9 years after allogeneic bone marrow transplantation for T-cell acute lymphoblastic leukaemia.
Trimble MS; Waye JS; Walker IR; Brain MC; Leber BF
Br J Haematol; 1993 Sep; 85(1):99-102. PubMed ID: 8251416
[TBL] [Abstract][Full Text] [Related]
34. Donor-derived breast cancer in a bone marrow transplantation recipient.
Golfinopoulos V; Pentheroudakis G; Kamakari S; Metaxa-Mariatou V; Pavlidis N
Breast Cancer Res Treat; 2009 Jan; 113(2):211-3. PubMed ID: 18264757
[TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
[TBL] [Abstract][Full Text] [Related]
36. Myeloid leukemia after cytotoxic therapy and other hematotoxins.
Larson RA
J Toxicol Environ Health A; 2000 Nov; 61(5-6):381-6. PubMed ID: 11086943
[No Abstract] [Full Text] [Related]
37. Conjunctival carcinoma as a novel post-stem cell transplantation malignancy.
Hon C; Au WY; Liang RH
Bone Marrow Transplant; 2004 Jul; 34(2):181-2. PubMed ID: 15133488
[No Abstract] [Full Text] [Related]
38. Soft tissue sarcoma in the setting of chronic cutaneous graft versus host disease after allogenic bone marrow transplantation.
Bylund KC; Giampoli E; Singh D; Doerr T; Sahasrabudhe D; Liesveld J; Constine LS
Cancer Invest; 2008 Jul; 26(6):638-41. PubMed ID: 18584356
[TBL] [Abstract][Full Text] [Related]
39. Recent developments in acute myelogenous leukemia therapy.
King ME; Rowe JM
Oncologist; 2007; 12 Suppl 2():14-21. PubMed ID: 18039635
[TBL] [Abstract][Full Text] [Related]
40. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
